|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Chinese expert consensus on conversion therapy for hepatocellular carcinoma(2021 edition)显示文摘Recent advances in systemic and locoregional treatments for patients with unresectable or advanced hepatocellular carcinoma(HCC)have resulted in improved response rates.This has provided an opportunity for selected patients with initially unresectable HCC to achieve adequate tumor downstaging to undergo surgical resection,a‘conversion therapy’strategy.However,conversion therapy is a new approach to the treatment of HCC and its practice and treatment protocols are still being developed.Review the evidence for conversion therapy in HCC and develop consensus statements to guide clinical practice.Evidence review:Many research centers in China have accumulated significant experience implementing HCC conversion therapy.Preliminary findings and data have shown that conversion therapy represents an important strategy to maximize the survival of selected patients with intermediate stage to advanced HCC;however,there are still many urgent clinical and scientific challenges for this therapeutic strategy and its related fields.In order to summarize and learn from past experience and review current challenges,the Chinese Expert Consensus on Conversion Therapy for Hepatocellular Carcinoma(2021 Edition)was developed based on a review of preliminary experience and clinical data from Chinese and non-Chinese studies in this field and combined with recommendations for clinical practice.Sixteen consensus statements on the implementation of conversion therapy for HCC were developed.The statements generated in this review are based on a review of clinical evidence and real clinical experience and will help guide future progress in conversion therapy for patients with HCC. | Hui-Chuan Sun Jian Zhou Zheng Wang Xiufeng Liu Qing Xie Weidong Jia Ming Zhao Xinyu Bi Gong Li Xueli Bai Yuan Ji Li Xu Xiao-Dong Zhu Dousheng Bai Yajin Chen Yongjun Chen Chaoliu Dai Rongping Guo Wenzhi Guo Chunyi Hao Tao Huang Zhiyong Huang Deyu Li Gang Li Tao Li Xiangcheng Li Guangming Li Xiao Liang Jingfeng Liu Fubao Liu Shichun Lu Zheng Lu Weifu Lv Yilei Mao Guoliang Shao Yinghong Shi Tianqiang Song Guang Tan Yunqiang Tang Kaishan Tao Chidan Wan Guangyi Wang Lu Wang Shunxiang Wang Tianfu Wen Baocai Xing Bangde Xiang Sheng Yan Dinghua Yang Guowen Yin Tao Yin Zhenyu Yin Zhengping Yu Bixiang Zhang Jialin Zhang Shuijun Zhang Ti Zhang Yamin Zhang Yubao Zhang Aibin Zhang Haitao Zhao Ledu Zhou Wu Zhang Zhenyu Zhu Shukui Qin Feng Shen Xiujun Cai Gaojun Teng Jianqiang Cai Minshan Chen Qiang Li Lianxin Liu Weilin Wang Tingbo Liang Jiahong Dong Xiaoping Chen Xuehao Wang Shusen Zheng Jia Fan 无 | 2022 | Hepatobiliary Surgery and Nutrition2022，11，2： | 4 |
| 2 | Microbiological Characteristics and Antibiotic Susceptibility in Liver Cirrhosis Patients With Nosocomial Spontaneous Bacterial Peritonitis Caused by Escherichia coli:A Multicenter Study显示文摘Escherichia coli is a prevalent causative pathogen of spontaneous bacterial peritonitis(SBP).In this retrospective study,we investigated the microbiological characteristics and antibiotic susceptibility of E.coli clinical isolates obtained from liver cirrhosis patients suffering from nosocomial SBP.Our results showed that extended-spectrum b-lactamase(ESBL)-producing E.coli accounted for 47%of the cases,while 62%of the isolates were multi-drug resistant(MDR)pathogens.ESBL-producing and MDR isolates showed high incidences of resistance to third-generation cephalosporins,but they displayed susceptibility to carbapenems,b-lactamase inhibitors,and aminoglycosides.Importantly,liver cirrhosis patients with MDR E.coli SBP showed a significantly higher death rate than patients with non-MDR infections(P=0.021).The 30-day mortality of nosocomial SBP was independently correlated with female gender[odds ratio(OR)=5.200,95%confidence interval(CI)=1.194–22.642],liver failure(OR=9.609,95%CI=1.914–48.225),hepatocellular carcinoma(OR=8.176,95%CI=2.065–32.364),hepatic encephalopathy(OR=8.176,95%CI=2.065–32.364),model of end-stage liver disease score(OR=1.191,95%CI=1.053–1.346),white blood cell count(OR=0.847,95%CI=0.737–0.973),and ascites polymorphonuclear(OR=95.903,95%CI=3.410–2697.356).In conclusion,third-generation cephalosporins may be inappropriate for empiric treatment of nosocomial SBP caused by E.coli,due to the widespread presence of ESBLs and high incidence of MDR pathogens. | Bo Tu Yuening Zhang Jingfeng Bi Zhe Xu Lei Shi Xin Zhang Peng Zhao Dawei Zhang Guang Yang Enqiang Qin | 2020 | Infectious Microbes & Diseases2020，2，4： | 1 |
| 3 | Transfer-free chemical vapor deposition graphene for nitride epitaxy: challenges, current status and future outlook显示文摘Graphene, a two-dimensional material with outstanding electrical and mechanical properties, has attracted considerable attention in the field of semiconductor technologies due to its potential use as a buffer layer for the epitaxial Ⅲ-nitride growth. In recent years, significant progress has been made in the chemical vapor deposition growth of graphene on various insulating substrates for the nitride epitaxy, which offers a facile, inexpensive, and easily scalable methodology. However, certain challenges are still present in the form of producing high-quality graphene and achieving optimal interface compatibility with Ⅲ-nitride materials.In this review, we provide an overview of the bottlenecks associated with the transferred graphene fabrication techniques and the state-of-the-art techniques for the transfer-free graphene growth. The present contribution highlights the current progress in the transfer-free graphene growth on different insulating substrates, including sapphire, quartz, SiO_(2)/Si, and discusses the potential applications of transfer-free graphene in the Ⅲ-nitride epitaxy. Finally, it includes the prospects of the transfer-free graphene growth for the Ⅲ-nitride epitaxy and the challenges that should be overcome to realize its full potential in this field. | Xiang Gao Senlin Li Jingfeng Bi Kaixuan Zhou Meng Li Zhongfan Liu Jingyu Sun | 2024 | Science China Chemistry2024，67，3： | 0 |
| 4 | Expert consensus on organizing the multidisciplinary team(MDT) diagnosis and treatment of hepato-pancreato-biliary diseases in China显示文摘Multidisciplinary team(MDT) discussion has been well established in some European countries and widely carried out in various clinical professional fields(Festen et al.,2021;Fleissig et al.,2006).Many studies have reported the benefits of MDT,including improving survival and quality of cancer care(Munro et al.,2015;Nixon et al.,2021;Tsai et al.,2020). | Binhao Zhang Jian Zhou Weifen Xie Kaishan Tao Shichun Lu Xianglin Yuan Lianxin Liu Weilin Wang Yilei Mao Ping Bie Jingfeng Liu Xinyu Bi Zhiwei Zhang Changhong Liang Jianqiang Cai Zhixiang Jian Yi Lv Peng Zhu Wei Zhang Hongqiang Yang Weiping Zhou Bixiang Zhang Xiaoping Chen | 2022 | Science China(Life Sciences)2022，65，5： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员